Current perspectives on the diagnosis and management of fatigue in multiple sclerosis

O Marchesi, C Vizzino, M Filippi… - Expert Review of …, 2022 - Taylor & Francis
Introduction Fatigue is a common and debilitating symptom among multiple sclerosis (MS)
patients with a prevalence up to 81% and with a considerable impact on quality of life …

[HTML][HTML] Early use of high-efficacy therapies in multiple sclerosis in the United States: benefits, barriers, and strategies for encouraging adoption

BA Singer, J Feng, H Chiong-Rivero - Journal of Neurology, 2024 - Springer
Multiple sclerosis (MS) is characterized by progressive neuroinflammation and
neurodegeneration from disease onset that, if left untreated, can result in the accumulation …

[HTML][HTML] Astrocyte signaling and interactions in Multiple Sclerosis

CC Ortiz, C Eroglu - Current Opinion in Cell Biology, 2024 - Elsevier
Multiple Sclerosis (MS) is a common cause of impairment in working-aged adults. MS is
characterized by neuroinflammation and infiltration of peripheral immune cells to the brain …

[HTML][HTML] Fatigue and health-related quality of life depend on the disability status and clinical course in RRMS

H Ahvenjärvi, M Niiranen, S Simula… - Multiple sclerosis and …, 2023 - Elsevier
Background Fatigue is a prominent and disabling symptom of multiple sclerosis (MS),
impairing quality of life. The disease course of relapsing remitting MS (RRMS) is individual …

[HTML][HTML] Prevalence, treatment and correlates of depression in multiple sclerosis

CA Young, D Langdon, D Rog, SK Chhetri… - Multiple Sclerosis and …, 2024 - Elsevier
Background The prevalence of depression in Multiple Sclerosis (MS) is often assessed by
administering patient reported outcome measures (PROMs) examining depressive …

[HTML][HTML] The effects of continuous care model using a smartphone application on adherence to treatment and self-efficacy among patients with multiple sclerosis

SM Kazemi, M Rakhshan, M Rivaz, S Izadi - BMC Medical Informatics and …, 2022 - Springer
Background Adherence to disease-modifying therapy is important in patients with Multiple
Sclerosis (MS) to increase the positive outcomes and improve the quality of life. This study …

[HTML][HTML] An Online Single-Session Cognitive Behavioral Therapy for Depression and Anxiety Associated with Multiple Sclerosis—Pilot Study

A Schenk, CO Popa, CM Cojocaru, Ș Marian… - Behavioral …, 2024 - mdpi.com
Background: Multiple sclerosis (MS) is one of the most debilitating neurodegenerative
diseases in youth, significantly affecting all life domains. Therefore, a strong association …

[HTML][HTML] Dilatation of the bridging cerebral veins in multiple sclerosis correlates with fatigue and suggests an increase in pressure

GA Bateman, AR Bateman, J Lechner-Scott - Multiple Sclerosis and …, 2023 - Elsevier
Background There is a significant increase in the parenchymal microvessel blood volume in
the earliest forms of multiple sclerosis (MS) which may be due to venular dilatation …

Neuroimaging correlates of patient-reported outcomes in multiple sclerosis

D Jakimovski, TR Wicks, N Bergsland… - Degenerative …, 2023 - Taylor & Francis
Background Patient-reported outcomes (PROs) are increasingly associated with concurrent
and future impairments in persons with multiple sclerosis (pwMS). The structural and …

Relationship between engagement in meaningful activities, self-efficacy, and quality of life in healthy young adults: An exploratory study

D Romero-Ayuso, A Jara-Urzúa… - Scandinavian Journal …, 2023 - Taylor & Francis
Background The use of meaningful activities promotes health and well-being. There is no
study with a healthy adult Spanish population that tries to determine how people engage in …